PuriCore Share Price (PURI)

20.75 -0.25 (-1.19%) delayed: 9:22AM BST
Bid price 20.00 Open price 21.00
Ask price 21.50 Prev close 21.00
High price 0.00 Spread 6.98%
Low price 0.00 Volume 0

Register now for FREE live PuriCore share prices, PuriCore stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get PuriCore Level 2 Data, indepth research tools and investor commentary for PuriCore (PURI) and other London Stock Exchange equities.

PuriCore Share Price Chart

Advanced Charts >>

Register now for FREE PuriCore share price charts

PuriCore Share Price Information

Name PuriCore Epic PURI
Sector Health Care Equipment & Services ISIN GB00B3XBCR18
Activites PuriCore develops and commercializes proprietary products that safely, effectively, and naturally kill contagious pathogens including major public health threats—M.tuberculosis, MRSA, E.coli, norovirus, avian influenza, HIV, polio virus, Helicobater pylori, and Legionella. Our products generate hypochlorous acid, the same natural anti-microbial produced by the human body to fight pathogens. Hypochlorous acid is highly effective in killing all types of bacteria, viruses, and fungal spores. PuriCore's technology and solutions are used in a broad range of markets that depend upon controlling contamination, including endoscopy, food retail, foodservice, hospitality, institutional, and wound therapy. Our antimicrobial solution is deployed as soaks, sprays, mists, and in other forms to limit the spread of infectious disease. The patented technologies use a simple combination of water, salt, and electricity to produce the same powerful solution found in the human immune system. PuriCore's highly sophisticated processes and controls allow the production of these unique biocidal solutions with a variety of different chemical and microbiological properties for use in specific settings and applications. Index n/a

PuriCore Key Numbers

Latest Share Price (p) 20.75 Net Gearing (%) -40.41
Market Capitalisation (£m) 10.53 Gross Gearing (%) 21.97
Shares in issue (m) 50.14 Debt Ratio 0.00
P/E Ratio -1.11 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.28
Dividend Yield (%) 0.00 Price to book value 0.54
Dividend cover (x) 0.00 ROCE (%) -48.29
Earning per share (p) -19.00 EPS Growth (%) -165.52
52 week high / low 28.00 / 17.50 DPS Growth (%) n/a

PuriCore Director Deals

Dec.Date Type Director Pos No. of Shares
29/03/2016 BUY Alex Martin CEO 100,000
14/10/2015 BUY Daniel Hegglin NED 500,000
28/09/2015 BUY Daniel Hegglin NED 500,000
28/09/2015 BUY Charles Spicer CH 77,922
02/04/2015 BUY Charles Spicer CH 50,610

More PuriCore Director Deals >>

PuriCore Company News

07:00 18/08/2016

Block listing Interim Review

/* */ RNS Number : 5714G PuriCore Plc 18 August 2016   PuriCore plc Block Listing Interim Review   Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies PuriCore plc makes the following update on its block listing:   Date:...

07:32 17/08/2016

PruiCore receives two US patents

PuriCore said the US Patent and Trademark Office has issued two new patents in connection with the company's making and use of hypochlorous acid preparations as a novel immunomodulatory therapy for inflammatory skin disorders. The patents cover method of production, formulations and method of...

07:00 17/08/2016

PuriCore Receives Two U.S. Patents

/* */ RNS Number : 3653H PuriCore Plc 17 August 2016     PuriCore plc ("PuriCore" or the "the Company")   PuriCore Receives Two U.S. Patents Covering Drug Development in Inflammatory Skin Diseases   17 August 2016 -...

More PuriCore Company News >>

Register now for FREE PuriCore company news

PuriCore Share Price Discussions

more than 1 year ago

PuriCore plc (PURI)

PuriCore specializes in developing and commercializing solutions to protect against the spread of infectious pathogens. Our proprietary products are effective while being completely safe for human and animal health and the environment. PuriCore has broad experience in key markets that...

more than 1 year ago

Puricore - US FDA approval and US Supermarket interest (PURI)

This one has come to my attention after a sudden surge from the bottom of its price range. In the last two weeks, PURI has announced US FDA approval to market its Sterilox Endoscopy High-Level Disinfectant System as a medical device in the US; also announced first prelims showing increasing...

Register now for FREE PuriCore share price discussions